ClinicalTrials.Veeva

Menu

New Therapeutic Approach Against BK Virus Infection Based on Monoclonal Antibodies (AcMBK)

U

University Hospital, Strasbourg, France

Status

Enrolling

Conditions

BK Virus Infection

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

BK virus (BKV) infection has a major negative impact on transplant recipients. No BKV-specific antiviral therapy is available, so there is an urgent need to develop new anti-BKV preventive and therapeutic strategies.

Enrollment

100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • BK positive
  • adult
  • ok to participed to research

Exclusion criteria

  • under guardianship
  • under curatorship
  • opposed to research
  • deprived of liberty

Trial contacts and locations

1

Loading...

Central trial contact

Anne-Sophie U GEY

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems